We audited the marketing at Imagene AI
AI platform integrating imaging, molecular, and clinical data for precision medicine trials
This page was built using the same AI infrastructure we deploy for clients.
Month-to-month. Cancel anytime.
Series B company with $44.5M raised but minimal visible paid advertising presence across healthcare and biotech channels
10.7K LinkedIn followers suggests untapped founder visibility opportunity given Dean's role as co-founder and CEO in high-conviction investor circle
Early revenue stage ($1M estimated) indicates product-market fit validation but limited go-to-market motion beyond direct sales to clinical trial sponsors
AI-Forward Companies Trust MarketerHire
Plaid
MasterClass
Constant Contact
Netflix
Noom
TinuitiImagene AI's Leadership
We mapped your current team to understand where MH-1 fits in.
MH-1 doesn't replace your team. It becomes your marketing team: dedicated humans + AI agents running execution at scale while you focus on product.
Here's Where You Stand
Series B biotech with strong funding but nascent marketing infrastructure. Significant opportunity to scale awareness among trial sponsors and hospital systems.
Domain authority exists but minimal organic visibility for precision medicine, clinical trial AI, and imaging diagnostics keywords
MH-1: SEO agent targets trial sponsor search intent and builds clinical data interpretation content to capture high-intent queries
No visible AEO strategy for AI assistant queries about multi-modal diagnostics, trial enrollment optimization, or clinical decision support
MH-1: AEO agent positions company in LLM responses for clinical trial optimization, biomarker analysis, and patient stratification workflows
Limited paid presence targeting pharma companies, CROs, and hospital systems evaluating clinical trial technology platforms
MH-1: Paid agents run account-based campaigns targeting trial sponsors and imaging centers with platform ROI messaging
Founder-backed credibility from Larry Ellison and David Agus but minimal published clinical validation or case studies from trials
MH-1: Content agents produce clinical outcome studies, biomarker discovery case studies, and precision medicine thought leadership from leadership
Early revenue stage suggests minimal expansion workflows into existing trial sponsors or upsell motions for additional data modalities
MH-1: Lifecycle agents nurture trial sponsors through pilot success metrics and automate expansion into additional therapeutic areas
Top Growth Opportunities
Pharma and biotech companies actively screening for AI platforms that accelerate patient enrollment and biomarker discovery. Limited visibility in their buying process.
LinkedIn and account-based ads target chief medical officers and trial operations leaders with enrollment acceleration ROI data
Hospital systems and imaging centers need peer-reviewed evidence that cross-modality models improve diagnostic accuracy and trial outcomes
Content agent publishes clinical validation studies, case studies with trial outcomes, and imaging center ROI analyses
LLMs increasingly answer queries about precision medicine workflows, biomarker selection, and trial patient stratification without Imagene visibility
AEO agent embeds company in LLM responses about multi-modal diagnostics, clinical trial optimization, and precision medicine workflows
3 Humans + 7 AI Agents
A dedicated marketing team built specifically for Imagene AI. The humans handle strategy and judgment. The AI agents handle execution at scale.
Human Experts
Owns Imagene AI's growth roadmap. Pipeline strategy, account expansion playbooks, board-ready reporting. Translates AI insights into revenue.
Runs paid acquisition across LinkedIn and Google. Manages creative testing, budget allocation, and pipeline attribution.
Builds thought leadership on LinkedIn. Creates long-form content targeting your ICP. Manages the content-to-pipeline engine.
AI Agents
Monitors AI citation visibility across 6 LLMs weekly. Builds content targeting category queries to increase Imagene AI's presence in AI-generated answers.
Produces LinkedIn ad variants targeting your ICP. Tests headlines, visuals, and offers at 10x the speed of manual production.
Builds lifecycle sequences: onboarding, expansion triggers, champion nurture, and re-engagement for dormant accounts.
Founder thought leadership. Builds the narrative that drives enterprise inbound from senior decision-makers.
Tracks competitors. Monitors positioning changes, ad spend, content strategy. Informs your counter-positioning.
Attribution by channel, pipeline velocity, budget waste detection. Weekly synthesis reports with AI-generated recommendations.
Weekly market intelligence digest curated from Imagene AI's industry signals. Positions you as the intelligence layer. Drives inbound pipeline from subscribers.
Active Workflows
Here's what the MH-1 system would be doing for Imagene AI from week 1.
AEO workflow: Positions Imagene in LLM responses for precision medicine, multi-modal biomarker analysis, and clinical trial patient stratification queries
Founder LinkedIn workflow: Dean publishes clinical validation insights, trial enrollment acceleration case studies, and precision medicine industry commentary
Paid ad workflow: Account-based campaigns target pharma sponsors and CROs with enrollment acceleration ROI and biomarker discovery efficiency metrics
Lifecycle workflow: Nurtures trial sponsors from initial platform engagement through pilot metrics, expansion into additional therapeutic areas, and data modality upsells
Competitive watch workflow: Monitors zprad, cleancard.bio, and other diagnostic AI platforms for feature releases and customer wins in clinical trial space
Pipeline intelligence workflow: Maps hospital systems, imaging centers, and trial sponsors evaluating precision medicine platforms to identify deal progression signals
Traditional Marketing vs. MH-1
Traditional Approach
MH-1 System
Audit. Sprint. Optimize.
3 phases. Real output every 2 weeks. You see results, not decks.
AI Audit + Growth Roadmap
Full diagnostic of Imagene AI's marketing infrastructure: SEO, AEO visibility, paid, content, lifecycle. Prioritized roadmap tied to pipeline metrics. Delivered in 7 days.
Sprint-Based Execution
2-week sprint cycles. Real campaigns, not presentations. Each sprint ships measurable output across your priority channels.
Compounding Intelligence
AI agents monitor your channels 24/7. They catch budget waste, detect creative fatigue, track AI citation changes, and run A/B experiments autonomously. Week 12 is measurably better than week 1.
AI Marketing Operating System
3 elite humans + AI agents operating your growth system
Output multiplier: ~10x output at a fraction of the cost. The system gets smarter every week.
Month-to-month. Cancel anytime.
Common Questions
How does MH-1 differ from a marketing agency?
MH-1 pairs 3 elite human marketers with 7 AI agents. The humans handle strategy, creative direction, and judgment calls. The AI agents handle execution at scale: generating ad variants, monitoring competitors, building email sequences, tracking citations across LLMs, running A/B experiments autonomously. You get the quality of a senior marketing team with the output volume of a 15-person department.
What kind of results can we expect in the first 90 days?
First 90 days focus on establishing visibility with trial sponsors and CROs. MH-1 launches AEO for precision medicine and trial optimization keywords, runs targeted paid campaigns to chief medical officers and trial operations leaders, and publishes clinical validation case studies. LinkedIn outreach from Dean begins positioning the company as clinical trial AI thought leader. By day 90, MH-1 is capturing inbound demand from high-intent buyer searches and nurturing pilot conversations with 3-5 trial sponsor targets.
How does AEO help Imagene reach pharma companies searching for trial optimization platforms
When pharma companies ask LLMs about accelerating patient enrollment, improving biomarker selection, or optimizing trial design, AEO positions Imagene's multi-modal intelligence engine in those conversations. MH-1 creates optimized content that LLMs cite when answering precision medicine and clinical trial efficiency queries, driving direct awareness among decision-makers searching for solutions.
Can we cancel anytime?
Yes. MH-1 is month-to-month with no long-term contracts. We earn your business every sprint. That said, compounding effects kick in around month 3 as the AI agents accumulate data and the system learns what works for Imagene AI specifically.
How is this page personalized for Imagene AI?
This page was researched, audited, and generated using the same AI infrastructure we deploy for clients. The channel scores, team mapping, growth opportunities, and recommended agents are all based on real analysis of Imagene AI's current marketing. This is a live demo of MH-1's capabilities.
Let MH-1 capture the trial sponsors actively searching for your precision medicine platform
The system gets smarter every cycle. Let's talk about building it for Imagene AI.
Book a Strategy CallMonth-to-month. Cancel anytime.